ADVERTISEMENT
ADVERTISEMENT

404

Not Found

Is this what you were looking for?

2008 1 1 69 1

Impeding PD-1
Megan Scudellari | Oct 1, 2008 | 4 min read
The discovery that blocking an inhibitory immune receptor restores T cell function in HIV sheds light on immune dysfunction.
FDA's 1st Chief Scientist speaks
Bob Grant | Apr 15, 2008 | 2 min read
Last week, the US Food and Drug Administration linkurl:named;http://www.fda.gov/bbs/topics/NEWS/2008/NEW01816.html cancer biologist linkurl:Frank Torti;http://www1.wfubmc.edu/canbio/Faculty/Torti+F.htm as the agency's first ever Chief Scientist. Torti, who is also the director of Wake Forest's linkurl:Comprehensive Cancer Center,;http://www1.wfubmc.edu/cancer/ will leave North Carolina and begin work early next month at the FDA. The researcher and clinician took time to talk with me and share hi
Peer-review-less grants, round 1
Bob Grant | Oct 18, 2009 | 2 min read
University College London (UCL), which last year linkurl:announced;http://www.the-scientist.com/blog/display/55282/ plans to award unorthodox research grants without robust peer review, deadlines, directives, or milestones, has linkurl:chosen;http://www.ucl.ac.uk/media/library/VentureLane its first awardee -- a biochemist who will study the evolutionary switch from simple to more complex cellular structures. The researcher, linkurl:Nick Lane,;http://www.nick-lane.net/index.html was deemed worth
1st ever retraction for JEB
Elie Dolgin | Nov 18, 2008 | 3 min read
The __Journal of Experimental Biology__ (JEB) has issued the first retraction in its 85 year history, the journal reported in an linkurl:editorial;http://jeb.biologists.org/cgi/content/full/211/23/3651 and a linkurl:retraction;http://jeb.biologists.org/cgi/content/full/211/23/3764 notice in its December 1 issue. Although the authors' institution told JEB their reuse of images was a careless error, the journal's editor-in-chief called it a case of outright fraud. The linkurl:retracted paper;http
Evolutionists Present Their 1.3% Solution
Leslie Pray | Aug 18, 2002 | 6 min read
In 1975, Mary-Claire King and the late Allan Wilson, both then at the University of California, Berkeley, showed that the genetic distance between humans and chimpanzees is simply too small to account for the dramatic anatomical and behavioral differences between the two species.1 No matter what method scientists used to measure genetic distance--protein electrophoresis, DNA hybridization, immunology, or amino acid sequencing--the result was always the same: Humans and chimpanzees are 98.7% ge
1st cancer vaccine approved in Russia
Alla Katsnelson | Apr 8, 2008 | 2 min read
A New York-based biotech company announced today (April 8) that it has received approval for the first linkurl:therapeutic cancer vaccine;http://www.the-scientist.com/article/display/18859/ -- in Russia. It is the first approval by a regulatory body of a cancer immunotherapy. The therapy's approval in Russia won't in itself boost its chances for approval in the US or the EU, or improve the prospects of other cancer vaccines that are in the biotech pipeline, Ren Benjamin, senior biotech analyst
NIH to act on conflicts within 1 year
Bob Grant | Dec 4, 2008 | 2 min read
The National Institutes of Health may change its regulations for managing financial conflict of interest among extramural grantees within 12 months, the acting director of the NIH said today (Dec. 5). "In roughly six months to a year, we're going to have action on this," NIH's acting director linkurl:Raynard Kington;http://www.nih.gov/about/director/directorbio.htm told an linkurl:advisory committee,;http://acd.od.nih.gov/ adding that there may be legislative action forcing the NIH to alter its
Different colored cartoon viruses entering holes in a cartoon of a human brain.
A Journey Into the Brain
Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
A close up of a tick held in a pair of forceps, with Kevin Esvelt’s face out of focus in the background.
CRISPR Gene Drives and the Future of Evolution
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.
A needle drawing up fluid from an unlabeled vial.
Cancer Vaccination as a Promising New Treatment Against Tumors
Shelby Bradford, PhD | Mar 15, 2024 | 10+ min read
Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.

Run a Search

ADVERTISEMENT